MedTrace Logo

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1

NCT05006924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2025-04-27

No results posted yet for this study

Summary

Myotonic Dystrophy type 1 (DM1) is a multisystem disease that causes muscle weakness and myotonia. As a result upper limb function might become impaired. In this study we will examine patients with DM1 and record their upper limb function. We will will use a battery of patient reported outcomes (PROs) and Outcome measures (OMs) in order to evalute which ones are suitable for use in clinical practise and research studies.

Conditions

  • Myotonic Dystrophy 1

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • Haukeland University Hospital

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Kristin L Ørstavik, PHD · Oslo University Hospital

  • Hilde S Robinson, PHD · University of Oslo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-10
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006924 on ClinicalTrials.gov